Home
Membership
- Current Members
Initiatives
Advocacy
About
CRO Forum

Medicines and Healthcare products Regulatory Agency Guidance: Managing Clinical Trials During COVID-19

April 14, 2020 By Beekeeper Team

Previous Article

European Medicines Agency Guidance: Points to Consider on Implications of Coronavirus Disease (COVID-19) on Methodological Aspects of Ongoing Clinical Trials

Next Article

Food and Drug Administration Press Release: COVID-19 Update: FDA Continues to Facilitate Development of Treatments

Recent Posts

2022 Officers and New Member Announcement
OPINION: Clinical Trials in the Spotlight: How to Solidify the Progress Made
ACRO Releases Toolkit to Help Advance Decentralized Clinical Trials
ACRO Applauds Release of Cures 2.0 Draft Legislation
ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring

About ACRO

The Association of Clinical Research Organizations (ACRO) and its members collaborate in pursuit of a global regulatory and business environment that fosters efficient, effective & safe clinical research.

Subscribe

Get in Touch

601 New Jersey Ave NW, #350,
Washington DC 20001
info@acrohealth.org
+1 (202) 464-9340

© ACRO 2022